Title 21 published on 09-Jun-2018 03:51
The following are ALL rules, proposed rules, and notices (chronologically) published in the Federal Register relating to 21 CFR Part 14 after this date.
2017-12-13; vol. 82 # 238 - Wednesday, December 13, 2017 82 FR 58553 - Advisory Committee; Food Advisory Committee; Termination
GPO FDSys XML | Text Additional Documents DEPARTMENT OF HEALTH AND HUMAN SERVICES, Food and Drug Administration Final rule. This rule is effective December 13, 2017. 21 CFR Part 14 Summary The Food and Drug Administration (FDA) is announcing the termination of the Food Advisory Committee. This document removes the Food Advisory Committee from the Agency's list of standing advisory committees.
2016-07-14; vol. 81 # 135 - Thursday, July 14, 2016 81 FR 45409 - Removal of Review and Reclassification Procedures for Biological Products Licensed Prior to July 1, 1972; Technical Amendment
GPO FDSys XML | Text Additional Documents DEPARTMENT OF HEALTH AND HUMAN SERVICES, Food and Drug Administration Final rule; technical amendment. This rule is effective July 14, 2016. 21 CFR Parts 14 and 20 Summary The Food and Drug Administration (FDA or Agency) is amending the Agency's regulations by removing certain regulations that include obsolete references. FDA is taking this action to improve the accuracy of the regulations.
2016-06-09; vol. 81 # 111 - Thursday, June 9, 2016 81 FR 37153 - Advisory Committee; Transmissible Spongiform Encephalopathies Advisory Committee; Termination
GPO FDSys XML | Text Additional Documents DEPARTMENT OF HEALTH AND HUMAN SERVICES, Food and Drug Administration Final rule. This rule is effective June 9, 2016. 21 CFR Part 14 Summary The Food and Drug Administration (FDA) is announcing the termination of the Transmissible Spongiform Encephalopathies Advisory Committee. This document removes the Transmissible Spongiform Encephalopathies Advisory Committee from the Agency's list of standing advisory committees.
2016-03-21; vol. 81 # 54 - Monday, March 21, 2016 81 FR 14975 - Patient Engagement Advisory Committee
GPO FDSys XML | Text Additional Documents DEPARTMENT OF HEALTH AND HUMAN SERVICES, Food and Drug Administration Final rule. This rule is effective March 21, 2016. 21 CFR Part 14 Summary The Food and Drug Administration (FDA) is amending the standing advisory committees' regulations to add the Patient Engagement Advisory Committee.
2016-03-07; vol. 81 # 44 - Monday, March 7, 2016 81 FR 11663 - Pharmaceutical Science and Clinical Pharmacology Advisory Committee
GPO FDSys XML | Text Additional Documents DEPARTMENT OF HEALTH AND HUMAN SERVICES, Food and Drug Administration Final rule. This rule is effective March 7, 2016. The name change became applicable January 22, 2016. 21 CFR Part 14 Summary The Food and Drug Administration (FDA) is amending the standing advisory committees' regulations to change the name of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology. This action is being taken to reflect the change made to the charter for this advisory committee.
2015-04-06; vol. 80 # 65 - Monday, April 6, 2015 80 FR 18307 - Advisory Committee; Anti-Infective Drugs Advisory Committee
GPO FDSys XML | Text Additional Documents DEPARTMENT OF HEALTH AND HUMAN SERVICES, Food and Drug Administration Final rule. This rule is effective April 6, 2015. The name change became applicable March 4, 2015. 21 CFR Part 14 Summary The Food and Drug Administration (FDA) is amending the standing advisory committees' regulations to change the name of the Anti-Infective Drugs Advisory Committee. This action is being taken to change the name of this committee on the Agency's list of standing advisory committees.
2015-03-20; vol. 80 # 54 - Friday, March 20, 2015 80 FR 14838 - Advisory Committee; Antiviral Drugs Advisory Committee; Termination
GPO FDSys XML | Text Additional Documents DEPARTMENT OF HEALTH AND HUMAN SERVICES, Food and Drug Administration Final rule. This rule is effective March 20, 2015. 21 CFR Part 14 Summary The Food and Drug Administration (FDA) is announcing the termination of the Antiviral Drugs Advisory Committee. This document removes the Antiviral Drugs Advisory Committee from the Agency's list of standing advisory committees.
2014-11-14; vol. 79 # 220 - Friday, November 14, 2014 79 FR 68114 - Division of Freedom of Information; Change of Office Name, and Removal of Address, Telephone Number, and Fax Number; Technical Amendment
GPO FDSys XML | Text Additional Documents DEPARTMENT OF HEALTH AND HUMAN SERVICES, Food and Drug Administration Final rule; technical amendments. This rule is effective November 14, 2014. 21 CFR Parts 5, 10, 14, 20, 21, 314, 350, 516, and 814 Summary The Food and Drug Administration (FDA) is amending the Agency's regulations to change the Division of Freedom of Information's (FOI's) name, and remove the address, telephone number, fax number, and Public Reading Room fax number and room number and replace them with FOI's address located on the Agency's Web site. This action is editorial in nature and is intended to improve the accuracy of the Agency's regulations.
2014-04-11; vol. 79 # 70 - Friday, April 11, 2014 79 FR 20094 - Advisory Committee: Bone, Reproductive and Urologic Drugs Advisory Committee
GPO FDSys XML | Text Additional Documents DEPARTMENT OF HEALTH AND HUMAN SERVICES, Food and Drug Administration Final rule. This rule is effective April 11, 2014. 21 CFR Part 14 Summary The Food and Drug Administration (FDA) is amending the standing advisory committees' regulations to change the name and function of the Advisory Committee for Reproductive Health Drugs. This action is being taken to reflect changes made to the charter for this advisory committee.
2014-01-13; vol. 79 # 8 - Monday, January 13, 2014 79 FR 2093 - Advisory Committee; Pharmacy Compounding Advisory Committee
GPO FDSys XML | Text Additional Documents DEPARTMENT OF HEALTH AND HUMAN SERVICES, Food and Drug Administration Final rule. This rule is effective January 13, 2014. 21 CFR Part 14 Summary The Food and Drug Administration (FDA) is amending its regulations to update information regarding the Pharmacy Compounding Advisory Committee in FDA's Center for Drug Evaluation and Research in the Agency's list of standing advisory committees. This updated information regarding the Committee includes changes to its charter to reflect the recent enactment of the Drug Quality and Security Act.
2013-11-22; vol. 78 # 226 - Friday, November 22, 2013 78 FR 69991 - Advisory Committee; Veterinary Medicine Advisory Committee; Termination
GPO FDSys XML | Text Additional Documents DEPARTMENT OF HEALTH AND HUMAN SERVICES, Food and Drug Administration Final rule. This rule is effective November 22, 2013. 21 CFR Part 14 Summary The Food and Drug Administration (FDA) is announcing the termination of the Veterinary Medicine Advisory Committee. This document removes the Veterinary Advisory Committee from the Agency's list of standing advisory committees.
2013-03-20; vol. 78 # 54 - Wednesday, March 20, 2013 78 FR 17086 - Public Hearing Before a Public Advisory Committee; Technical Amendments
GPO FDSys XML | Text Additional Documents DEPARTMENT OF HEALTH AND HUMAN SERVICES, Food and Drug Administration Final rule; technical amendments. This rule is effective March 20, 2013. 21 CFR Part 14 Summary The Food and Drug Administration (FDA) is amending its regulations regarding advisory committees to address minor technical changes and corrections to statutory citations. This action is editorial in nature and is intended to provide accuracy and clarity to the Agency's regulations.
